Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ikuo Inoue

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 15, 2005
[Hyperlipidemia and peroxisome proliferator-activated receptor (PPAR)--regulation of the PPARalpha gene by CLOCK: BMAL1]Ikuo Inoue
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 8, 2007
[Familial combined hyperlipidemia]Ikuo Inoue
Clinical Calcium|November 8, 2005
[Lipid metabolism and magnesium]Ikuo Inoue
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 8, 2007
[The drug treatment for hyperlipidemic patient with diabetes mellitus--pharmacology based medicine and pathogenesis based medicine]Ikuo Inoue
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 20, 2011
[Proper use of the dietary supplement (food with health claims) and the formula diet for metabolic syndrome patients]Ikuo Inoue, Shigehiro Katayama
Current Drug Targets. Cardiovascular & Haematological Disorders|March 23, 2004
The possible therapeutic actions of peroxisome proliferator-activated receptor alpha (PPAR alpha) agonists, PPAR gamma agonists, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, angiotensin converting enzyme (ACE) inhibitors and calcium (Ca)-antagonists on vascular endothelial cellsIkuo Inoue, Shigehiro Katayama
The Journal of Veterinary Medical Science|December 22, 2012
Efficacy of fosfomycin on Escherichia coli isolated from bitches with pyometraIkuo Inoue, Sanae Shibata, Tsuneo Fukata
Internal Medicine (Tokyo, Japan)|August 2, 2021
Neurofibromatosis Type 1 with Concurrent Multiple Endocrine Disorders: Adenomatous Goiter, Primary Hyperparathyroidism, and AcromegalyShigemitsu Yasuda, Ikuo Inoue, Akira Shimada
Nutrients|February 6, 2019
A Newly Integrated Model for Intestinal Cholesterol Absorption and Efflux Reappraises How Plant Sterol Intake Reduces Circulating Cholesterol LevelsTakanari Nakano, Ikuo Inoue, Takayuki Murakoshi
Recent Patents on Cardiovascular Drug Discovery|April 29, 2010
Retrospective, observation study: Quantitative and qualitative effect of ezetimibe and HMG-CoA reductase inhibitors on LDL-cholesterol: are there disappearance thresholds for small, dense LDL and IDL?Ikuo Inoue, Takuya Awata, Shigehiro Katayama
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 15, 2005
[Hyperlipidemia and peroxisome proliferator-activated receptor (PPAR)--regulation of the PPARalpha gene by CLOCK: BMAL1]Ikuo Inoue
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 8, 2007
[Familial combined hyperlipidemia]Ikuo Inoue
Clinical Calcium|November 8, 2005
[Lipid metabolism and magnesium]Ikuo Inoue
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 8, 2007
[The drug treatment for hyperlipidemic patient with diabetes mellitus--pharmacology based medicine and pathogenesis based medicine]Ikuo Inoue
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 20, 2011
[Proper use of the dietary supplement (food with health claims) and the formula diet for metabolic syndrome patients]Ikuo Inoue, Shigehiro Katayama
Current Drug Targets. Cardiovascular & Haematological Disorders|March 23, 2004
The possible therapeutic actions of peroxisome proliferator-activated receptor alpha (PPAR alpha) agonists, PPAR gamma agonists, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, angiotensin converting enzyme (ACE) inhibitors and calcium (Ca)-antagonists on vascular endothelial cellsIkuo Inoue, Shigehiro Katayama
The Journal of Veterinary Medical Science|December 22, 2012
Efficacy of fosfomycin on Escherichia coli isolated from bitches with pyometraIkuo Inoue, Sanae Shibata, Tsuneo Fukata
Internal Medicine (Tokyo, Japan)|August 2, 2021
Neurofibromatosis Type 1 with Concurrent Multiple Endocrine Disorders: Adenomatous Goiter, Primary Hyperparathyroidism, and AcromegalyShigemitsu Yasuda, Ikuo Inoue, Akira Shimada
Nutrients|February 6, 2019
A Newly Integrated Model for Intestinal Cholesterol Absorption and Efflux Reappraises How Plant Sterol Intake Reduces Circulating Cholesterol LevelsTakanari Nakano, Ikuo Inoue, Takayuki Murakoshi
Recent Patents on Cardiovascular Drug Discovery|April 29, 2010
Retrospective, observation study: Quantitative and qualitative effect of ezetimibe and HMG-CoA reductase inhibitors on LDL-cholesterol: are there disappearance thresholds for small, dense LDL and IDL?Ikuo Inoue, Takuya Awata, Shigehiro Katayama
Pageof 10